Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, April 4, 2023
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
Mon, April 3, 2023
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
Reni Benjamin Maintained (STRO) at Buy with Decreased Target to $17 on, Apr 3rd, 2023
Reni Benjamin of JMP Securities, Maintained "Sutro Biopharma, Inc." (STRO) at Buy with Decreased Target from $20 to $17 on, Apr 3rd, 2023.
Reni has made no other calls on STRO in the last 4 months.
There are 4 other peers that have a rating on STRO. Out of the 4 peers that are also analyzing STRO, 0 agree with Reni's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Reni
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $16 on, Friday, March 31st, 2023
- David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $20 on, Friday, March 31st, 2023
- Asthika Goonewardene of "Truist Securities" Maintained at Strong Buy with Increased Target to $25 on, Friday, January 13th, 2023
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $18 on, Tuesday, January 10th, 2023
